The investment will be used to expand the Indian geographical footprint of the international eye care chain, along with latest technology for super specialty eye-care
Dr Agarwal’s Healthcare Ltd (DAHCL) has raised ₹ 270-crore investment from Temasek, a global investment company headquartered in Singapore. The investment will be used to expand the Indian geographical footprint of the international eye care chain, along with significant investments in latest technology for super specialty eye-care.
Temasek is a global investor anchored in Asia, with India accounting for around 4 per cent of its S$308 billion ($235b) portfolio as on March 31, 2018. Temasek‘s healthcare portfolio in India includes investments in Medanta MediCity, Manipal Hospitals and HealthCare Global.
“The Agarwal Group is excited to welcome Temasek as an investor. We believe their expertise and support will help our company expand our network of clinics and operations to better meet the growing demand for affordable and quality eye care across India,” said Prof (Dr) Amar Agarwal, Chairman, Dr Agarwal’s Group of Eye Hospitals.
Dr Adil Agarwal, CEO, Dr Agarwal’s Group of Eye Hospitals said, “We are looking at adding anywhere between 50-75 hospitals to our network over the next three to five years with a major focus on metro cities as well as tier 2 and tier 3 towns. The expansion will be done through a mix of strategic partnerships, acquisitions and greenfield hospitals. Innovation and technology will continue to be at the forefront of our growth, and we will be investing more in cutting edge technology such as SMILE, FemtoLaser and Robotic Cataract Surgery across our centres. Our aim is to deliver high quality eye care at affordable prices at people’s doorsteps.”